IGC PHARMA, INC. Debt Instrument, Interest Rate During Period
IGC PHARMA, INC. (IGC) reported Debt Instrument, Interest Rate During Period of 3.00% for the 12-month period ending 2021-03-31, per its 10-K filed 2021-06-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateDuringPeriod · last filed 2021-06-14
- IGC PHARMA, INC. debt instrument, interest rate during period for the quarter ending 2020-06-30 was 3.00%, a 0.00% change year-over-year.
- IGC PHARMA, INC. debt instrument, interest rate during period for the quarter ending 2019-06-30 was 3.00%.
- IGC PHARMA, INC. debt instrument, interest rate during period for fiscal 2021 was 3.00%, a 0.00% change from fiscal 2020.
- IGC PHARMA, INC. debt instrument, interest rate during period for fiscal 2020 was 3.00%, a 0.00% change from fiscal 2019.
- IGC PHARMA, INC. debt instrument, interest rate during period for fiscal 2019 was 3.00%.
| Period end | Debt Instrument, Interest Rate During Period 3 month | Debt Instrument, Interest Rate During Period 6 month | Debt Instrument, Interest Rate During Period 9 month | Debt Instrument, Interest Rate During Period 12 month |
|---|---|---|---|---|
| 2021-03-31 | 3.00% 10-K · filed 2021-06-14 | |||
| 2020-12-31 | 3.00% 10-Q · filed 2021-02-16 | |||
| 2020-09-30 | 3.00% 10-Q · filed 2020-11-20 | |||
| 2020-06-30 | 3.00% 10-Q · filed 2020-08-19 | |||
| 2020-03-31 | 3.00% 10-K · filed 2020-07-13 | |||
| 2019-12-31 | 3.00% 10-Q · filed 2020-02-10 | |||
| 2019-09-30 | 3.00% 10-Q · filed 2019-11-06 | |||
| 2019-06-30 | 3.00% 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | 3.00% 10-K · filed 2019-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |